https://scholars.lib.ntu.edu.tw/handle/123456789/635185
標題: | Effectiveness of second-generation integrase strand-transfer inhibitor-based regimens for antiretroviral-experienced people with HIV who had viral rebound | 作者: | Chen, Guan-Jhou HSIN-YUN SUN SUI-YUAN CHANG SZU-MIN HSIEH WANG-HUEI SHENG YU-CHUNG CHUANG YU-SHAN HUANG KUAN-YIN LIN Liu, Wen-Chun Su, Yi-Ching CHIEN-CHING HUNG |
關鍵字: | Bictegravir; Dolutegravir; Genetic barrier; Nucleoside reverse-transcriptase inhibitor; Resistance-associated mutation; Salvage therapy; Virologic failure | 公開日期: | 4-八月-2023 | 來源出版物: | Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi | 摘要: | Antiretroviral regimens containing a second-generation integrase strand-transfer inhibitor (INSTI) plus 2 nucleos(t)ide reverse-transcriptase inhibitors (NRTIs) are the recommended therapy for people with HIV (PWH) who are antiretroviral-naïve or on stable antiretroviral therapy (ART) with viral suppression. Real-world data on the virologic effectiveness of co-formulated bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) among PWH with virologic failure while receiving other ART remain sparse. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/635185 | ISSN: | 16841182 | DOI: | 10.1016/j.jmii.2023.07.013 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。